- Victoza is injected under the skin of the abdomen, thigh, or upper arm.
- Each pre-filled pen can deliver 0.6, 1.2, and 1.8 mg doses. The initial dose is 0.6 mg daily for one week.
- The initial dose helps the body to build a tolerance to stomach related side effects.
- Victoza is not effective for controlling blood glucose.
- After one week the dose is increased to 1.2 mg daily.
- The maximum dose is 1.8 mg daily.
- Victoza slows down transit of food and drugs through the intestine and, therefore, may reduce the absorption of drugs that are taken orally. Although Victoza did not significantly affect the absorption of oral dugs tested in studies, it is still prudent to separate administration of Victoza and oral medications.
- Combining Victoza with insulin or drugs that stimulate release of insulin (for example, glyburide [Micronase, Diabeta, Glynase, Prestab]) may increase the occurrence of low blood sugar (hypoglycemia). The dose of insulin or the insulin release stimulating drug should be reduced.
PREGNANCY AND BREASTFEEDING SAFETY:
- There are no adequate studies of Victoza in pregnant women. Most experts agree that insulin is the drug of choice in pregnant women with diabetes.
- There are no adequate studies of Victoza in nursing mothers, and it is not known whether Victoza is excreted in human breast milk.
Quick GuideDiabetes Diet: Healthy Meal Plans for Diabetes-Friendly Eating
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.